PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 12325097

The Cochrane Collaboration - how is it progressing?

Andreas Laupacis
View original source ↗Export metadata ↓

Abstract

During the last seven years, the Cochrane Collaboration has rapidly developed into an important international organization, producing high quality systematic reviews of randomized trials. Challenges, which it will likely meet, include maintaining the quality of the reviews, ensuring that reviews are done of the most common therapies for important diseases, securing stable funding, and making the format of the reviews more accessible for the average clinician.

Explore related subjects

Evidence-Based MedicineHumansInformation ServicesRandomized Controlled Trials as TopicReview Literature as TopicJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Andreas Laupacis. 2002-10-15. The Cochrane Collaboration - how is it progressing?. https://doi.org/10.1002/sim.1285

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

[Acute and transient psychotic disorders (ICD-10: F23). Empirical data and implications for therapy].

The defining clinical features of acute and transient psychotic disorders (ICD-10: F23) are an acute onset and a duration of psychotic symptoms not exceeding 1-3 months. Previous empirical investigations show that patients with this diagnosis have a favourable prognosis, but also a high risk of relapses (58-77%). The diagnostic stability in the further course of illness seems to be low (34-73%) with a frequent diagnostic change to schizophrenia and affective disorders being observed. As yet, data from controlled clinical trials regarding therapy do not exist. The implications for the treatment of acute and transient psychotic disorders are discussed with this background.

Evidence-Based Medicine↗